Skip to content

Author

Angelo M. Patti

We have 3 of 84 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity.

AIMS/HYPOTHESIS Obesity drives cardiometabolic dysfunction and increases cardiovascular risk, with excess fat mass and impaired body composition playing a key role in metabolic outcomes. This clinical study aimed to evaluate the real-world effectiveness (RWE) of tirzepatide on body weight, body composition, and metabol...

Davide Brancato, V. Maggio, Francesca Vaccaro et al. · 0 citations
Open access Sep 2026

Effects of Glucoerb® and Epavin® on Cardiometabolic Profile in Adults with Overweight or Obesity: A Three-Month Real-World Study

Background/Objectives: Overweight and obesity are major drivers of cardiometabolic dysfunction and increase the risk of type 2 diabetes (T2DM)and cardiovascular disease. Although lifestyle intervention remains the cornerstone of treatment, complementary strategies may provide additional benefits. The effects of Glucoer...

V. Maggio, Francesca Vaccaro, Elena Muratore et al. · 0 citations
Review Open access Aug 2026

Endothelial Dysfunction and Obesity: New Diagnostic and Therapeutic Strategies

The evidence supports an integrated and personalized management strategy targeting both metabolic and vascular abnormalities to reduce cardiovascular risk and improve long-term clinical outcomes in individuals with obesity.

R. V. Giglio, S. Stanković, Angelo M. Patti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.